搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Shewanella baltica 30S ribosomal protein S10 (rpsJ) CSB-YP493068SYS
CSB-EP493068SYS
CSB-BP493068SYS
CSB-MP493068SYS
CSB-EP493068SYS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella baltica Glutamate racemase (murI) CSB-YP493069SYS
CSB-EP493069SYS
CSB-BP493069SYS
CSB-MP493069SYS
CSB-EP493069SYS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella baltica Ribosome maturation factor RimM (rimM) CSB-YP493070SYS
CSB-EP493070SYS
CSB-BP493070SYS
CSB-MP493070SYS
CSB-EP493070SYS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella baltica Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp) CSB-YP493071SYS
CSB-EP493071SYS
CSB-BP493071SYS
CSB-MP493071SYS
CSB-EP493071SYS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella baltica Na (+)-translocating NADH-quinone reductase subunit D, partial CSB-YP493072SYS1
CSB-EP493072SYS1
CSB-BP493072SYS1
CSB-MP493072SYS1
CSB-EP493072SYS1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella baltica LexA repressor (lexA) CSB-YP493073SYS
CSB-EP493073SYS
CSB-BP493073SYS
CSB-MP493073SYS
CSB-EP493073SYS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella baltica Formamidopyrimidine-DNA glycosylase (mutM) CSB-YP493074SYS
CSB-EP493074SYS
CSB-BP493074SYS
CSB-MP493074SYS
CSB-EP493074SYS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella baltica ATP synthase gamma chain (atpG) CSB-YP493075SYS
CSB-EP493075SYS
CSB-BP493075SYS
CSB-MP493075SYS
CSB-EP493075SYS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella baltica 50S ribosomal protein L34 (rpmH) CSB-YP493076SYS
CSB-EP493076SYS
CSB-BP493076SYS
CSB-MP493076SYS
CSB-EP493076SYS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella baltica L-arabinose isomerase (araA) CSB-YP493077SYS
CSB-EP493077SYS
CSB-BP493077SYS
CSB-MP493077SYS
CSB-EP493077SYS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella baltica Serine--tRNA ligase (serS) CSB-YP493078SYS
CSB-EP493078SYS
CSB-BP493078SYS
CSB-MP493078SYS
CSB-EP493078SYS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella baltica Isoleucine--tRNA ligase (ileS), partial CSB-YP493079SYS
CSB-EP493079SYS
CSB-BP493079SYS
CSB-MP493079SYS
CSB-EP493079SYS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylocella silvestris Probable transcriptional regulatory protein Msil_2305 (Msil_2305) CSB-YP493080MTF
CSB-EP493080MTF
CSB-BP493080MTF
CSB-MP493080MTF
CSB-EP493080MTF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylocella silvestris Dihydrodipicolinate reductase (dapB) CSB-YP493081MTF
CSB-EP493081MTF
CSB-BP493081MTF
CSB-MP493081MTF
CSB-EP493081MTF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylocella silvestris Phosphopantetheine adenylyltransferase (coaD) CSB-YP493082MTF
CSB-EP493082MTF
CSB-BP493082MTF
CSB-MP493082MTF
CSB-EP493082MTF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylocella silvestris Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp) CSB-YP493083MTF
CSB-EP493083MTF
CSB-BP493083MTF
CSB-MP493083MTF
CSB-EP493083MTF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylocella silvestris UPF0060 membrane protein Msil_1658 (Msil_1658), partial CSB-YP493084MTF1
CSB-EP493084MTF1
CSB-BP493084MTF1
CSB-MP493084MTF1
CSB-EP493084MTF1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylocella silvestris 30S ribosomal protein S4 (rpsD) CSB-YP493085MTF
CSB-EP493085MTF
CSB-BP493085MTF
CSB-MP493085MTF
CSB-EP493085MTF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylocella silvestris 30S ribosomal protein S8 (rpsH) CSB-YP493086MTF
CSB-EP493086MTF
CSB-BP493086MTF
CSB-MP493086MTF
CSB-EP493086MTF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylocella silvestris 30S ribosomal protein S19 (rpsS) CSB-YP493087MTF
CSB-EP493087MTF
CSB-BP493087MTF
CSB-MP493087MTF
CSB-EP493087MTF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶(hù)提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€(xiàn)留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>